ストックスクリーナーアプリを入手
389.09
1.11%
-4.35
プレマーケット:
392.89
3.80
+0.98%
前日終値:
$393.44
開ける：
$392.8
24時間の取引高:
1.20M
Relative Volume:
0.68
時価総額：
$84.38B
収益：
$201.11B
当期純損益:
$4.95B
株価収益率:
17.29
EPS:
22.4991
ネットキャッシュフロー:
$6.29B
1週間 パフォーマンス:
-0.32%
1か月 パフォーマンス:
-1.45%
6か月 パフォーマンス:
+4.53%
1年 パフォーマンス:
+38.11%
1日の値動き範囲:
$386.93
$396.00
1週間の範囲:
$365.38
$396.05
52週間の値動き範囲:
$273.71
$436.24
Elevance Health Inc Stock (ELV) Company Profile
名前
Elevance Health Inc
セクター
電話
(800) 331-1476
住所
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
389.09 | 84.38B | 201.11B | 4.95B | 6.29B | 22.50 |
UNH
Unitedhealth Group Inc
|
431.31 | 391.69B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
108.08 | 137.90B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
284.85 | 75.35B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
397.60 | 47.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-08 | 開始されました | Evercore ISI | In-line |
| 2026-02-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 開始されました | Goldman | Neutral |
| 2025-07-21 | ダウングレード | Argus | Buy → Hold |
| 2025-07-18 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | アップグレード | Argus | Hold → Buy |
| 2025-01-22 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | ダウングレード | Argus | Buy → Hold |
| 2024-07-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-06-24 | 開始されました | Morgan Stanley | Overweight |
| 2024-05-30 | 開始されました | Robert W. Baird | Outperform |
| 2024-03-06 | 開始されました | Barclays | Overweight |
| 2023-07-12 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-28 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
すべてを表示
Elevance Health Inc (ELV) 最新ニュース
AE1P Bond Profile — Key Metrics - TradingView
Elevance Health (ELV) Stock Still Looks Reasonable After A 43% Run - Yahoo Finance
Elevance Health stock trades steadily as earnings and Medicare growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance Health, Inc. (ELV) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
The Hidden Engine Behind Elevance Health Stock's Next Climb - Trefis
Elevance Health stock trades steadily as earnings and Medicaid growth shape investor focus - Ad-hoc-news.de
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health Inc Stock Price Live, Charts & News - The Economic Times
Elevance Health Chairman Ramiro Peru Buys $336,000 of Shares. What Does This Mean for Investors Right Now? - The Motley Fool
AE1D Bond Profile — Key Metrics - TradingView
AE1J Bond Profile — Key Metrics - TradingView
Elevance Health President Acquires 1.9% More Stock - Moomoo
Elevance Health, Inc. (ELV) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health director Peru buys $366,050 in company stock - Investing.com UK
Elevance Preparing to Exit Several Medicaid States - RamaOnHealthcare
Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 - Bitget
Elevance Health Price Target Raised to $395.00/Share From $364.00 by Leerink Partners - Moomoo
Insider Buying: Ramiro Peru Acquires Shares of Elevance Health I - GuruFocus
Elevance Health CEO Snaps Up Stock After Post-Earnings Slide - Barron's
Elevance Health director Peru buys $366,050 in company stock By Investing.com - Investing.com South Africa
Elevance Health, Inc. (ELV) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Elevance Health, Inc. $ELV Shares Acquired by Bank of New York Mellon Corp - InsuranceNewsNet
What's a Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets? - Trefis
Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook? - The Motley Fool
Elevance Health (NYSE: ELV) director purchases 1,000 shares at $366 - Stock Titan
Form 4 Elevance Health Inc For: 17 July By Investing.com - Investing.com South Africa
Elevance Health (NYSE: ELV) CEO Gail Boudreaux purchases 2,725 shares - Stock Titan
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock By Investing.com - Investing.com Australia
Elevance Health CEO Gail Boudreaux buys $1.0m in company stock - Investing.com Nigeria
Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform Rating - Moomoo
Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform Rating - Moomoo
Morgan Stanley Maintains Elevance Health(ELV.US) With Hold Rating, Maintains Target Price $404 - Moomoo
Elevance Health's Strong Q2 Prompts Higher 2026-27 Estimates, Truist Says - Moomoo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE) - The Globe and Mail
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings - Sahm
Elevance Health 2Q Medical Enrollment Members 44.9M >ELV - Moomoo
Elevance Health stock holds near earnings context - ad-hoc-news.de
Lobbying Update: $60,000 of ELEVANCE HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Elevance Health earnings call: growth levers amid strain - The Globe and Mail
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
AE1N Bond Profile — Key Metrics - TradingView
RBC Lowers Price Target on Elevance Health to $424 From $439, Keeps Sector Perform Rating - Moomoo
Goldman Sachs Adjusts Price Target on Elevance Health to $395 From $370, Maintains Neutral Rating - Moomoo
Guggenheim Adjusts Price Target on Elevance Health to $455 From $399, Maintains Buy Rating - Moomoo
Wells Fargo Adjusts Price Target on Elevance Health to $473 From $492, Maintains Overweight Rating - Moomoo
Elevance Health Stock Weakness Despite Q2 Beat Reflects Medicaid Utilization Pressure, RBC Capital Markets Says - marketscreener.com
Elevance Health Stock Tumbles Despite Revenue Beat and Raised Full-Year Guidance - TIKR.com
Elevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructive - Yahoo Finance
The Medicaid Problem Weighing On Elevance Health Stock - Trefis
Baird Adjusts Price Target on Elevance Health to $393 From $331, Maintains Neutral Rating - marketscreener.com
Elevance Health Inc (ELV) 財務データ
収益
当期純利益
現金流量
EPS
1.94%
1.71%
大文字化:
|
ボリューム (24 時間):